MorphoLens 6 slide scanner
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institutes of Health (NIH), specifically the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), has issued a Notice of Intent to award a Firm-Fixed-Price Purchase Order to Morphle Labs Inc. for a MorphoLens 6 slide scanner. This acquisition is intended to support preclinical disease research by digitizing histology slides. While the intent is to sole source, this is a Total Small Business Set-Aside opportunity, and small businesses are invited to submit capability statements. Responses are due by June 5, 2026.
Purpose & Scope
The NIDDK, Liver Diseases Branch, requires a MorphoLens 6 slide scanner to digitize histology slides from mice tissues. This equipment is crucial for ongoing preclinical disease research, enabling efficient processing, visualization, and documentation of histology slides. The scanner will be used to assess disease progression, tissue morphology, and treatment response.
Key Requirements
The required slide scanner must be capable of:
- Digitizing histology slides.
- Having a minimum loading capacity of six slides for efficient batch processing.
- Providing high-resolution imaging for accurate visualization and documentation of cellular structures and tissue pathology.
Contract Details
- Anticipated Contract Type: Firm-Fixed-Price Purchase Order.
- Place of Performance: Bethesda, MD 20892, United States.
Set-Aside & Eligibility
This opportunity is designated as a Total Small Business Set-Aside (FAR 19.5). Although the NIH intends to award to Morphle Labs Inc. as the sole responsible source, small businesses (including 8(a), service-disabled veteran owned, HUBZone, small disadvantaged, veteran-owned, and women-owned) are strongly encouraged to submit a written capability statement. The Government will determine whether to compete the award based on the responses received.
Submission & Evaluation
This is not a request for competitive quotes. Interested small businesses must submit a written capability statement demonstrating their ability to meet the requirement. Responses should be sent via email to david.shen@nih.gov. The Government reserves the right to decide whether to compete the award based on the capabilities demonstrated.
Response Deadline & Contact
- Capability Statements Due: June 5, 2026, by 11:00 p.m. EDT.
- Contact: David Shen (david.shen@nih.gov).
- Anticipated Award: Approximately ten (10) days after the notice date, unless another vendor demonstrates capability.